Immediate Impact
13 standout
Citing Papers
Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future
2022 Standout
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol
2022 Standout
Works of Erin Ohmann being referenced
Nationwide, population-based study of prostate cancer stage migration between and within clinical risk categories
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Erin Ohmann | 65 | 57 | 46 | 17 | 207 | |
| J. Boletis | 38 | 23 | 64 | 18 | 207 | |
| Hollie M. Reeves | 31 | 16 | 35 | 15 | 291 | |
| Shawn E. Parnell | 74 | 4 | 51 | 19 | 221 | |
| Carla Golden | 24 | 6 | 65 | 15 | 257 | |
| Irene M. Irving | 171 | 4 | 42 | 15 | 295 | |
| Arnaud Isapof | 20 | 18 | 7 | 20 | 272 | |
| A. Sherif | 77 | 14 | 12 | 16 | 137 | |
| DAVID B. LASHLEY | 102 | 8 | 87 | 17 | 287 | |
| Amit Bery | 125 | 35 | 35 | 18 | 234 | |
| Shinya Fukuda | 34 | 8 | 25 | 20 | 264 |
All Works
Loading papers...